Highlights
NASDAQ: AKCA       Akcea Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
13.94   +0.04 (0.29%)  13.66 - 14.28  109,177

Overview

 
Avg Volume (4 weeks):457,489
4 Weeks Range:12.63 - 17.09
4 Weeks Price Volatility (%):
29.37%
52 Weeks Range:8.00 - 25.66
52 Weeks Price Volatility (%):
33.64%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Akcea Therapeutics Inc is a late stage biopharmaceutical company focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. It is advancing a mature pipeline of novel drugs with the potential to treat multiple diseases. The company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. Its most advanced drug, volanesorsen, has completed a Phase 3 clinical program for the treatment of familial chylomicronemia syndrome, or FCS, and is currently in Phase 3 clinical development for the treatment of familial partial lipodystrophy, or FPL.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2073  3739  260  2992 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 9.185+1.275 
 GNUS 3.55+1.24 
 LK 1.38-1.62 
 SOLO 3.16+0.83 
 WKHS 20.33+1.15 
 AAL 12.62-0.19 
 AVP 5.60-0.05 
 SQQQ 7.055-0.235 
 PCG 9.533+0.503 
 GE 6.845+0.105 
Partners & Brokers